TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Polar Biomedicals AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
2,509
|
2,413
|
2,177 |
| Financial expenses |
26
|
42
|
26 |
| Earnings before taxes |
408
|
190
|
117 |
| Total assets |
1,449
|
1,213
|
1,167 |
| Current assets |
1,444
|
1,210
|
1,166 |
| Current liabilities |
528
|
508
|
444 |
| Equity capital |
921
|
705
|
722 |
| - share capital |
35
|
36
|
39 |
| Employees (average) | 2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
63.6%
|
58.1%
|
61.9% |
| Turnover per employee | 1,088 | ||
| Profit as a percentage of turnover |
16.3%
|
7.9%
|
5.4% |
| Return on assets (ROA) |
30.0%
|
19.1%
|
12.3% |
| Current ratio |
273.5%
|
238.2%
|
262.6% |
| Return on equity (ROE) |
44.3%
|
27.0%
|
16.2% |
| Change turnover |
220
|
374
|
-196 |
| Change turnover % |
10%
|
18%
|
-8% |
| Chg. No. of employees | 0 | ||
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.